Lifestyle modification and behavior therapy effectively reduce body weight and increase serum level of brain-derived neurotrophic factor in obese non-diabetic …
FC Kuo, CH Lee, CH Hsieh, P Kuo, YC Chen… - Psychiatry research, 2013 - Elsevier
The goal of the study was to elucidate the relationship between serum circulating brain-
derived neurotrophic factor (BDNF) and body weight reduction via lifestyle modification and
behavior therapy in obese non-diabetic patients with chronic schizophrenia. Thirty-three
obese non-diabetic subjects with schizophrenia treated with stable antipsychotic medication
in a day-care unit for at least 3 months were recruited. Thirty age-, body weight-matched
subjects without psychiatric disorders were enrolled as controls. All participants underwent a …
derived neurotrophic factor (BDNF) and body weight reduction via lifestyle modification and
behavior therapy in obese non-diabetic patients with chronic schizophrenia. Thirty-three
obese non-diabetic subjects with schizophrenia treated with stable antipsychotic medication
in a day-care unit for at least 3 months were recruited. Thirty age-, body weight-matched
subjects without psychiatric disorders were enrolled as controls. All participants underwent a …
Lifestyle modification and behavior therapy effectively reduce body weight and increase serum level of brain-derived neurotrophic factor in obese non-diabetic …
KFC Kuo FengChih, LCH Lee ChienHsing… - 2013 - cabidigitallibrary.org
The goal of the study was to elucidate the relationship between serum circulating brain-
derived neurotrophic factor (BDNF) and body weight reduction via lifestyle modification and
behavior therapy in obese non-diabetic patients with chronic schizophrenia. Thirty-three
obese non-diabetic subjects with schizophrenia treated with stable antipsychotic medication
in a day-care unit for at least 3 months were recruited. Thirty age-, body weight-matched
subjects without psychiatric disorders were enrolled as controls. All participants underwent a …
derived neurotrophic factor (BDNF) and body weight reduction via lifestyle modification and
behavior therapy in obese non-diabetic patients with chronic schizophrenia. Thirty-three
obese non-diabetic subjects with schizophrenia treated with stable antipsychotic medication
in a day-care unit for at least 3 months were recruited. Thirty age-, body weight-matched
subjects without psychiatric disorders were enrolled as controls. All participants underwent a …
以上显示的是最相近的搜索结果。 查看全部搜索结果